ZD 1839
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZD 1839, covering 2019-11-07 to 2020-04-06. Get the full timeline:
Most recent: Clinical Trial Update: ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]